(Q40504960)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15480420%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

title

The erythropoietin-receptor pathway modulates survival of cancer cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15480420%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15480420%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

author name string

Frank Pajonk

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15480420%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Antonia Weil

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15480420%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Alfred Sommer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15480420%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Michael Henke

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15480420%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

language of work or name

English

0 references

publication date

1 November 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15480420%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15480420%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15480420%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

issue

55

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15480420%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

page(s)

8987-8991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15480420%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.onc.1208140

4 January 2020

exact match

0 references

cites work

The pleiotropic effects of erythropoietin in the central nervous system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208140

Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208140

Anemia in cervical cancers: impact on survival, patterns of relapse, and association with hypoxia and angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208140

Multivariate regression analyses of data from a randomised, double-blind, placebo-controlled study confirm quality of life benefit of epoetin alfa in patients receiving non-platinum chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208140

Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: improvements in hemoglobin and quality of life are similar to three-times-weekly dosing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208140

The effect of recombinant human erythropoietin treatment on tumour radiosensitivity and cancer-associated anaemia in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208140

Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208140

Inhibition of NF-kappaB, clonogenicity, and radiosensitivity of human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208140

Proteasomes regulate erythropoietin receptor and signal transducer and activator of transcription 5 (STAT5) activation. Possible involvement of the ubiquitinated Cis protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208140

Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208140

7 January 2021

Computer programs for the analysis of cellular survival data.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208140

7 January 2021

NF-kappa B: ten years after

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208140

7 January 2021

Pediatric Tumor Cells Express Erythropoietin and a Functional Erythropoietin Receptor that Promotes Angiogenesis and Tumor Cell Survival

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208140

7 January 2021

Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208140

7 January 2021

Prevalence of anemia in cancer patients undergoing radiotherapy: prognostic significance and treatment.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208140

7 January 2021

Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208140

7 January 2021

The Effect of Alterations in Haematocrit on Tumour Sensitivity to X-rays

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208140

7 January 2021

The adaptive response of mouse tumours to anaemia and retransfusion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208140

7 January 2021

Tyrosine phosphorylation of I kappa B-alpha activates NF-kappa B without proteolytic degradation of I kappa B-alpha

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208140

7 January 2021

Correction of radiation sensitivity in ataxia telangiectasia cells by a truncated I kappa B-alpha

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208140

7 January 2021

Breast cancer trial with erythropoietin terminated unexpectedly

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208140

7 January 2021

Radiation therapy and the role of red blood cell transfusion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208140

7 January 2021

Erythropoietin as an angiogenic factor in gastric carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208140

7 January 2021

Erythropoietin increases the radioresistance of a clonal hematopoietic progenitor cell line expressing a transgene for the erythropoietin receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208140

7 January 2021

The effect of heterogeneity in tumor cell kinetics on radiation dose-response. An exploratory investigation of a plateau effect

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208140

7 January 2021

Erythropoietin and G-CSF receptors in human tumor cells: expression and aspects regarding functionality.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208140

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1208140

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15480420%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

4 January 2020

0 references

1 reference